unzaro is a new medicine developed to help people with diabetes and weight management. It works by improving how the body controls sugar and appetite. Known for its powerful results, it helps lower blood sugar and supports healthy weight loss. Made by Eli Lilly, Munzaro is now gaining global attention as the next big step after Ozempic.
What Is Mounjaro?
Mounjaro, the brand name for tirzepatide, is a revolutionary medication that activates both GIP and GLP-1 receptors. The FDA approved it in May 2022 to treat type 2 diabetes, and it later received approval for chronic weight management under the name Zepbound®. More recently, it has also been approved for treating obstructive sleep apnea, marking another milestone in its growing list of medical benefits.
Mounjaro Benefits and Medical Uses
Mounjaro has emerged as a breakthrough in modern medicine, redefining our approach towards diabetes and weight management. With its powerful dual-action formula, it’s transforming health outcomes and offering new hope for holistic wellness.
-
Improved Glycemic Control in Type 2 Diabetes
Clinical trials within the SURPASS program demonstrated that Mounjaro, when added to diet and exercise, delivered superior blood sugar control and weight loss compared to standard treatments like insulin or Ozempic/semaglutide.
Research has shown that adults with type 2 diabetes saw up to 15% body weight reduction with mounjaro. Another study revealed that non-diabetic individuals achieved up to 21% weight loss.
The SURMOUNT-1 trial reported an astounding 22.5% weight loss over 72 weeks, making Mounjaro one of the most effective weight loss medications available.
In SURMOUNT-2, patients with obesity and diabetes lost between 12.8% and 14.7% depending on dosage, along with major improvements in HbA1c levels.
Leading diabetes guidelines (ADA, AACE, EASD) now recommend tirzepatide as a preferred add-on therapy, especially for patients with overweight or obesity.
FDA approval now includes obstructive sleep apnea treatment and weight management under the Zepbound® brand.
Mounjaro Side Effects
-
Gastrointestinal issues such as nausea, diarrhea, appetite loss, vomiting, constipation, indigestion, and abdominal discomfort—especially during initial dosing. These usually improve within a few weeks.
-
Pancreatitis (inflammation of the pancreas) — monitor symptoms like severe abdominal/back pain.
-
Thyroid Tumor Risk (Black Box Warning) — animal studies showed thyroid C-cell tumors; avoid if there’s a history of medullary thyroid carcinoma or MEN2.
-
Hypoglycemia Risk — especially when used with insulin or sulfonylureas.
-
Kidney Problems from dehydration due to GI side effects.
-
Gastroparesis — delayed gastric emptying may cause persistent nausea or fullness.
-
Vision Changes / NAION — rare but serious vision concerns have been associated.
-
Gallbladder Issues, allergic reactions, and surgical complications are also possible.
Mounjaro in India
-
Mounjaro (tirzepatide) was officially launched in India in March 2025, after approval from the CDSCO (Central Drugs Standard Control Organization).
-
It is approved for both Type 2 diabetes and for managing chronic obesity/weight issues in adults, used along with diet and exercise.
-
Recently, the KwikPen pre-filled pen version of Mounjaro got regulatory approval. This will make usage more convenient compared to vials.
Price in India
-
Dosage strengths available initially: 2.5 mg and 5 mg vial forms.
-
Retail price per vial:
Strength Price per vial 2.5 mg ~ ₹3,500 5 mg ~ ₹4,375 -
Estimated monthly cost (depending on dose): ~ ₹14,000 to ₹17,500 for once-weekly injections.
-
Mounjaro is prescription-only, must be used under medical supervision.
-
It’s meant for use in people with obesity (BMI ≥ 30) or overweight (BMI ≥ 27) with related health issues. Also for Type 2 diabetes.
-
Doctors caution against misuse — especially using higher doses without proper follow-up, or without combining with lifestyle changes
Quick Summary Table
| Aspect | Details |
|---|---|
| Primary Uses | Type 2 diabetes, weight management, obstructive sleep apnea |
| Benefits | Significant weight loss, better blood sugar control, improved insulin response |
| Typical Side Effects | GI discomfort: nausea, appetite loss, vomiting, etc. |
| Serious Risks | Pancreatitis, thyroid tumor risk, hypoglycemia, kidney issues, vision problems |
End Note
With its entry into India, Mounjaro marks a major step forward in diabetes and weight management therapies. As awareness grows and accessibility improves, it holds the promise to transform countless lives struggling with metabolic health issues. However, its true success will depend on responsible use, medical guidance, and holistic lifestyle changes that ensure long-term well-being.